 Trevor Nydam
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 41 | 2025 | 800 | 8.070 |
Why?
| | Tissue and Organ Procurement | 9 | 2025 | 302 | 2.720 |
Why?
| | Gastric Bypass | 4 | 2023 | 106 | 2.560 |
Why?
| | Thrombelastography | 13 | 2024 | 148 | 2.420 |
Why?
| | Obesity, Morbid | 5 | 2024 | 241 | 2.370 |
Why?
| | Kidney Transplantation | 12 | 2024 | 638 | 2.270 |
Why?
| | Living Donors | 8 | 2022 | 298 | 2.000 |
Why?
| | Tissue Donors | 11 | 2025 | 398 | 1.960 |
Why?
| | Tissue Plasminogen Activator | 7 | 2023 | 225 | 1.960 |
Why?
| | Blood Coagulation Disorders | 4 | 2022 | 163 | 1.640 |
Why?
| | Death | 4 | 2023 | 124 | 1.620 |
Why?
| | Donor Selection | 6 | 2025 | 74 | 1.280 |
Why?
| | Fibrinolysis | 5 | 2023 | 135 | 1.260 |
Why?
| | Bariatric Surgery | 2 | 2023 | 190 | 1.240 |
Why?
| | Carcinoma, Hepatocellular | 8 | 2023 | 267 | 1.160 |
Why?
| | Graft Survival | 12 | 2025 | 523 | 1.130 |
Why?
| | Cold Ischemia | 4 | 2021 | 29 | 0.990 |
Why?
| | Liver Neoplasms | 8 | 2023 | 637 | 0.950 |
Why?
| | Kidney | 8 | 2022 | 1330 | 0.890 |
Why?
| | Delayed Graft Function | 3 | 2022 | 30 | 0.840 |
Why?
| | Hepatitis C | 3 | 2022 | 234 | 0.820 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 30 | 0.820 |
Why?
| | Organ Preservation | 4 | 2024 | 92 | 0.800 |
Why?
| | Resuscitation | 2 | 2024 | 244 | 0.790 |
Why?
| | End Stage Liver Disease | 6 | 2023 | 78 | 0.770 |
Why?
| | Blood Transfusion | 4 | 2019 | 294 | 0.760 |
Why?
| | Organ Transplantation | 3 | 2025 | 225 | 0.740 |
Why?
| | Gastrectomy | 5 | 2024 | 99 | 0.730 |
Why?
| | Reperfusion | 1 | 2020 | 37 | 0.700 |
Why?
| | Kidney Failure, Chronic | 3 | 2023 | 548 | 0.690 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 46 | 0.680 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 80 | 0.670 |
Why?
| | Hepatitis C, Chronic | 1 | 2022 | 154 | 0.660 |
Why?
| | Humans | 73 | 2025 | 128896 | 0.620 |
Why?
| | Graft Rejection | 2 | 2020 | 566 | 0.620 |
Why?
| | Heart Failure | 2 | 2023 | 2142 | 0.620 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 25 | 0.620 |
Why?
| | Postoperative Complications | 4 | 2024 | 2494 | 0.610 |
Why?
| | Apoptosis | 5 | 2021 | 2481 | 0.610 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 43 | 0.600 |
Why?
| | Caspase Inhibitors | 1 | 2018 | 83 | 0.600 |
Why?
| | Blood Coagulation | 6 | 2023 | 228 | 0.590 |
Why?
| | Thrombophilia | 1 | 2018 | 68 | 0.580 |
Why?
| | Pneumoperitoneum | 1 | 2017 | 11 | 0.580 |
Why?
| | Klebsiella Infections | 1 | 2017 | 23 | 0.580 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2018 | 72 | 0.580 |
Why?
| | Cholecystitis | 1 | 2017 | 23 | 0.570 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2024 | 952 | 0.570 |
Why?
| | Cholecystectomy | 1 | 2017 | 60 | 0.560 |
Why?
| | Heart Transplantation | 1 | 2023 | 713 | 0.560 |
Why?
| | Quinolines | 1 | 2018 | 149 | 0.560 |
Why?
| | Liver | 7 | 2022 | 1832 | 0.560 |
Why?
| | Retrospective Studies | 22 | 2024 | 14546 | 0.520 |
Why?
| | Middle Aged | 29 | 2024 | 30977 | 0.510 |
Why?
| | Parents | 2 | 2020 | 1301 | 0.470 |
Why?
| | Brain Death | 4 | 2025 | 44 | 0.450 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2024 | 255 | 0.440 |
Why?
| | Wounds and Injuries | 4 | 2019 | 718 | 0.410 |
Why?
| | Pancreatic Neoplasms | 4 | 2024 | 878 | 0.400 |
Why?
| | Acute Kidney Injury | 4 | 2021 | 786 | 0.390 |
Why?
| | Registries | 1 | 2020 | 1916 | 0.390 |
Why?
| | Male | 38 | 2024 | 63146 | 0.380 |
Why?
| | Creatinine | 4 | 2023 | 485 | 0.380 |
Why?
| | Decision Support Techniques | 4 | 2020 | 387 | 0.370 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2014 | 1204 | 0.370 |
Why?
| | Saline Solution, Hypertonic | 3 | 2014 | 40 | 0.370 |
Why?
| | Treatment Outcome | 16 | 2025 | 10239 | 0.360 |
Why?
| | Waiting Lists | 6 | 2025 | 242 | 0.350 |
Why?
| | Multiple Organ Failure | 1 | 2011 | 122 | 0.340 |
Why?
| | NF-kappa B | 4 | 2014 | 685 | 0.330 |
Why?
| | Adenocarcinoma | 3 | 2024 | 895 | 0.330 |
Why?
| | Female | 31 | 2024 | 68162 | 0.330 |
Why?
| | Transplant Recipients | 2 | 2022 | 156 | 0.320 |
Why?
| | Ablation Techniques | 2 | 2020 | 31 | 0.320 |
Why?
| | Warm Ischemia | 2 | 2020 | 12 | 0.310 |
Why?
| | Thrombocytopenia | 1 | 2011 | 187 | 0.310 |
Why?
| | Thrombosis | 3 | 2022 | 331 | 0.310 |
Why?
| | Adult | 21 | 2024 | 35361 | 0.300 |
Why?
| | United States | 14 | 2025 | 13975 | 0.300 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 1967 | 0.300 |
Why?
| | Obesity | 5 | 2024 | 2844 | 0.280 |
Why?
| | Time Factors | 11 | 2024 | 6568 | 0.270 |
Why?
| | Survival Rate | 5 | 2024 | 1884 | 0.270 |
Why?
| | Perfusion | 2 | 2024 | 191 | 0.270 |
Why?
| | Necrosis | 3 | 2021 | 234 | 0.260 |
Why?
| | Risk Factors | 11 | 2023 | 9792 | 0.250 |
Why?
| | Metabolomics | 3 | 2019 | 592 | 0.250 |
Why?
| | Epithelial Cells | 3 | 2014 | 1059 | 0.240 |
Why?
| | Aged | 15 | 2025 | 22035 | 0.240 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 361 | 0.240 |
Why?
| | Flank Pain | 1 | 2024 | 9 | 0.230 |
Why?
| | Coronavirus Infections | 2 | 2020 | 355 | 0.230 |
Why?
| | Prospective Studies | 4 | 2020 | 7060 | 0.230 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2024 | 6 | 0.230 |
Why?
| | Colonoscopy | 1 | 2007 | 225 | 0.230 |
Why?
| | Tumor Burden | 3 | 2020 | 284 | 0.230 |
Why?
| | Lung | 3 | 2014 | 3925 | 0.220 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 214 | 0.220 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 75 | 0.220 |
Why?
| | Salvage Therapy | 2 | 2024 | 136 | 0.210 |
Why?
| | Choledochostomy | 1 | 2022 | 11 | 0.210 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2022 | 27 | 0.200 |
Why?
| | Caspase 1 | 2 | 2021 | 143 | 0.200 |
Why?
| | Risk Assessment | 7 | 2022 | 3286 | 0.200 |
Why?
| | Antiviral Agents | 2 | 2022 | 708 | 0.200 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2022 | 86 | 0.200 |
Why?
| | Bile Ducts | 1 | 2022 | 66 | 0.200 |
Why?
| | Lymph | 2 | 2016 | 32 | 0.200 |
Why?
| | Allografts | 1 | 2023 | 138 | 0.200 |
Why?
| | Preoperative Period | 2 | 2019 | 112 | 0.190 |
Why?
| | Hemostatics | 1 | 2022 | 47 | 0.190 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 255 | 0.190 |
Why?
| | Nephrectomy | 2 | 2020 | 163 | 0.180 |
Why?
| | Reperfusion Injury | 2 | 2021 | 274 | 0.180 |
Why?
| | Intraoperative Period | 1 | 2020 | 53 | 0.180 |
Why?
| | Cell Line | 3 | 2018 | 2759 | 0.170 |
Why?
| | Computer Systems | 1 | 2020 | 48 | 0.170 |
Why?
| | Feasibility Studies | 1 | 2024 | 859 | 0.170 |
Why?
| | Viscosity | 1 | 2020 | 90 | 0.170 |
Why?
| | Models, Animal | 2 | 2020 | 370 | 0.170 |
Why?
| | Shock, Hemorrhagic | 2 | 2016 | 168 | 0.170 |
Why?
| | Pancreatectomy | 2 | 2024 | 245 | 0.170 |
Why?
| | Liver Function Tests | 1 | 2020 | 110 | 0.170 |
Why?
| | Blood Coagulation Tests | 1 | 2020 | 54 | 0.170 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 25 | 0.170 |
Why?
| | Hepacivirus | 1 | 2022 | 235 | 0.170 |
Why?
| | Caspase 3 | 2 | 2018 | 241 | 0.170 |
Why?
| | Thromboembolism | 1 | 2020 | 105 | 0.160 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 291 | 0.160 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 96 | 0.160 |
Why?
| | Liver Diseases | 1 | 2022 | 284 | 0.160 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 294 | 0.160 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 403 | 0.160 |
Why?
| | Weight Loss | 2 | 2024 | 723 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5270 | 0.150 |
Why?
| | Critical Care | 1 | 2023 | 547 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2020 | 4917 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2023 | 3334 | 0.140 |
Why?
| | Klebsiella pneumoniae | 1 | 2017 | 42 | 0.140 |
Why?
| | Plasma | 2 | 2016 | 198 | 0.140 |
Why?
| | Platelet Count | 2 | 2022 | 83 | 0.140 |
Why?
| | Drug Overdose | 1 | 2021 | 330 | 0.140 |
Why?
| | Young Adult | 7 | 2024 | 12286 | 0.140 |
Why?
| | Goals | 1 | 2018 | 161 | 0.140 |
Why?
| | Hepatectomy | 1 | 2018 | 205 | 0.130 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.130 |
Why?
| | Aortic Valve Insufficiency | 1 | 2015 | 47 | 0.120 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 295 | 0.120 |
Why?
| | Airway Extubation | 1 | 2016 | 53 | 0.120 |
Why?
| | Early Detection of Cancer | 1 | 2019 | 349 | 0.120 |
Why?
| | ABO Blood-Group System | 1 | 2015 | 40 | 0.120 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 42 | 0.120 |
Why?
| | Renal Artery | 1 | 2015 | 33 | 0.120 |
Why?
| | Isoantibodies | 1 | 2015 | 50 | 0.120 |
Why?
| | Microsurgery | 1 | 2015 | 68 | 0.120 |
Why?
| | Rewarming | 1 | 2014 | 19 | 0.120 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 146 | 0.120 |
Why?
| | Phosphorylation | 4 | 2014 | 1685 | 0.110 |
Why?
| | Kidney Tubules | 1 | 2014 | 114 | 0.110 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 311 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 502 | 0.110 |
Why?
| | Erythrocyte Transfusion | 2 | 2016 | 185 | 0.110 |
Why?
| | Incidence | 1 | 2020 | 2634 | 0.110 |
Why?
| | Age Factors | 4 | 2021 | 3133 | 0.110 |
Why?
| | Cholestasis | 1 | 2016 | 229 | 0.110 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2015 | 168 | 0.100 |
Why?
| | Metabolome | 1 | 2016 | 316 | 0.100 |
Why?
| | Osmolar Concentration | 1 | 2013 | 166 | 0.100 |
Why?
| | Health Services Accessibility | 1 | 2020 | 894 | 0.100 |
Why?
| | Biomarkers | 3 | 2019 | 3874 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1170 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2014 | 376 | 0.100 |
Why?
| | Sirolimus | 1 | 2013 | 194 | 0.100 |
Why?
| | Microvessels | 1 | 2013 | 79 | 0.100 |
Why?
| | Recovery of Function | 1 | 2016 | 641 | 0.100 |
Why?
| | Autophagy | 1 | 2014 | 263 | 0.100 |
Why?
| | Patient Selection | 1 | 2015 | 671 | 0.100 |
Why?
| | Aortic Valve Stenosis | 1 | 2015 | 291 | 0.100 |
Why?
| | Animals | 9 | 2021 | 34628 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3994 | 0.100 |
Why?
| | Models, Biological | 1 | 2019 | 1702 | 0.090 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 274 | 0.090 |
Why?
| | Neoplasms | 1 | 2025 | 2426 | 0.090 |
Why?
| | Markov Chains | 2 | 2020 | 124 | 0.080 |
Why?
| | Shock | 2 | 2024 | 96 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 699 | 0.080 |
Why?
| | Hypoxia | 1 | 2016 | 1070 | 0.080 |
Why?
| | Postoperative Period | 2 | 2020 | 319 | 0.080 |
Why?
| | Injury Severity Score | 1 | 2011 | 513 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1408 | 0.070 |
Why?
| | Mice | 6 | 2021 | 16543 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2020 | 149 | 0.070 |
Why?
| | Odds Ratio | 1 | 2011 | 1019 | 0.070 |
Why?
| | Renal Dialysis | 2 | 2023 | 417 | 0.070 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 383 | 0.070 |
Why?
| | Colonoscopes | 1 | 2007 | 5 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 423 | 0.070 |
Why?
| | Barium Sulfate | 1 | 2007 | 15 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 404 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2007 | 53 | 0.070 |
Why?
| | Cecum | 1 | 2007 | 32 | 0.070 |
Why?
| | Mesentery | 1 | 2007 | 47 | 0.070 |
Why?
| | Paraneoplastic Syndromes | 1 | 2007 | 12 | 0.070 |
Why?
| | Enema | 1 | 2007 | 43 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 266 | 0.070 |
Why?
| | Cause of Death | 2 | 2021 | 392 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2007 | 65 | 0.070 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2007 | 46 | 0.070 |
Why?
| | Blotting, Western | 1 | 2009 | 1188 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2009 | 543 | 0.070 |
Why?
| | Quality of Life | 1 | 2018 | 2706 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 503 | 0.060 |
Why?
| | Recurrence | 2 | 2023 | 1013 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1082 | 0.060 |
Why?
| | Logistic Models | 1 | 2011 | 1963 | 0.060 |
Why?
| | Survival Analysis | 2 | 2020 | 1282 | 0.060 |
Why?
| | Child | 6 | 2022 | 20824 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1146 | 0.060 |
Why?
| | Renal Veins | 1 | 2024 | 16 | 0.060 |
Why?
| | Adolescent | 5 | 2024 | 20197 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2019 | 659 | 0.060 |
Why?
| | Ampulla of Vater | 1 | 2024 | 39 | 0.060 |
Why?
| | Databases, Factual | 2 | 2021 | 1289 | 0.060 |
Why?
| | Trauma Centers | 1 | 2006 | 410 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2020 | 7050 | 0.060 |
Why?
| | Inflammation | 1 | 2014 | 2694 | 0.050 |
Why?
| | Erythrocytes | 1 | 2009 | 667 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 211 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1221 | 0.050 |
Why?
| | Robotic Surgical Procedures | 1 | 2024 | 108 | 0.050 |
Why?
| | Perioperative Period | 1 | 2022 | 49 | 0.050 |
Why?
| | ROC Curve | 1 | 2024 | 500 | 0.050 |
Why?
| | Propensity Score | 1 | 2023 | 262 | 0.050 |
Why?
| | Platelet Transfusion | 1 | 2022 | 58 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 489 | 0.050 |
Why?
| | Hemostasis | 1 | 2022 | 68 | 0.050 |
Why?
| | Patients | 1 | 2023 | 167 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2020 | 1285 | 0.050 |
Why?
| | Pandemics | 2 | 2020 | 1516 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1995 | 0.050 |
Why?
| | Child Abuse | 1 | 2006 | 518 | 0.050 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2020 | 8 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2767 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 85 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2530 | 0.040 |
Why?
| | Partial Thromboplastin Time | 1 | 2020 | 54 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2020 | 211 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 82 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2007 | 730 | 0.040 |
Why?
| | Blood Viscosity | 1 | 2019 | 16 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 5704 | 0.040 |
Why?
| | Databases as Topic | 1 | 1999 | 65 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 369 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2019 | 39 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 657 | 0.040 |
Why?
| | Long-Term Care | 1 | 1999 | 88 | 0.040 |
Why?
| | Ischemia | 1 | 2020 | 396 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 311 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2018 | 312 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 914 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 36 | 0.030 |
Why?
| | Sepsis | 1 | 2022 | 561 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 72 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 3671 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 343 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 57 | 0.030 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 29 | 0.030 |
Why?
| | Transplants | 1 | 2015 | 38 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 135 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 594 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 730 | 0.030 |
Why?
| | Endothelial Cells | 2 | 2013 | 734 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 4857 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 1999 | 637 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 149 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2770 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 479 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 85 | 0.030 |
Why?
| | Femoral Artery | 1 | 2015 | 176 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 484 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1213 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 753 | 0.030 |
Why?
| | Macrolides | 1 | 2014 | 62 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 343 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4048 | 0.030 |
Why?
| | Motivation | 1 | 2018 | 541 | 0.030 |
Why?
| | Reoperation | 1 | 2016 | 555 | 0.030 |
Why?
| | Hepatocytes | 1 | 2014 | 215 | 0.030 |
Why?
| | Leukocytes | 1 | 2014 | 301 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2013 | 151 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2603 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 267 | 0.020 |
Why?
| | Swine | 1 | 2014 | 740 | 0.020 |
Why?
| | Infant | 2 | 2021 | 8994 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2013 | 261 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2013 | 452 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1504 | 0.020 |
Why?
| | Cell Communication | 1 | 2013 | 292 | 0.020 |
Why?
| | Child, Preschool | 2 | 2021 | 10457 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3787 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1095 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2013 | 278 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2009 | 35 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 61 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2009 | 129 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1523 | 0.020 |
Why?
| | Veterans | 1 | 1999 | 1397 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3042 | 0.020 |
Why?
| | Neutrophils | 1 | 2013 | 1203 | 0.020 |
Why?
| | Laparotomy | 1 | 2007 | 108 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 848 | 0.020 |
Why?
| | Intestine, Small | 1 | 2007 | 140 | 0.020 |
Why?
| | Exons | 1 | 2007 | 330 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 877 | 0.020 |
Why?
| | Blood Preservation | 1 | 2009 | 271 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1091 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2007 | 569 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 427 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2308 | 0.010 |
Why?
| | Glucose | 1 | 2007 | 976 | 0.010 |
Why?
| | Manuals as Topic | 1 | 1999 | 14 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5236 | 0.010 |
Why?
| | Demography | 1 | 1999 | 280 | 0.010 |
Why?
| | Health Resources | 1 | 1999 | 121 | 0.010 |
Why?
| | Patient Admission | 1 | 1999 | 185 | 0.010 |
Why?
| | Nursing Homes | 1 | 1999 | 154 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 1999 | 258 | 0.010 |
Why?
| | Colorado | 1 | 2006 | 4443 | 0.010 |
Why?
| | Women's Health | 1 | 1999 | 361 | 0.010 |
Why?
| | Data Collection | 1 | 1999 | 652 | 0.010 |
Why?
| | Ambulatory Care | 1 | 1999 | 509 | 0.010 |
Why?
| | Internet | 1 | 1999 | 616 | 0.010 |
Why?
| | Sex Factors | 1 | 1999 | 1947 | 0.010 |
Why?
| | Hospitalization | 1 | 1999 | 2080 | 0.010 |
Why?
|
|
Nydam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|